Deerfield Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Deerfield Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,644,583	Closed	-$576K	–	129
2018 Q2	$576K	Hold	1,644,583	–	–	0.02%	114
2018 Q1	$2.47M	Hold	1,644,583	–	–	0.09%	107
2017 Q4	$2.33M	Hold	1,644,583	–	–	0.09%	89
2017 Q3	$3.77M	Hold	1,644,583	–	–	0.17%	83
2017 Q2	$2.22M	Hold	1,644,583	–	–	0.12%	79
2017 Q1	$3.52M	Hold	1,644,583	–	–	0.14%	91
2016 Q4	$7.25M	Hold	1,644,583	–	–	0.3%	68
2016 Q3	$7.98M	Hold	1,644,583	–	–	0.37%	51
2016 Q2	$5.43M	Hold	1,644,583	–	–	0.21%	71
2016 Q1	$5.84M	Buy	+1,644,583	New	+$8.48M	0.25%	68

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Deerfield Management's ARLZ Position: Q3 2018 in Review

Deerfield Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 1,644,583 shares — an estimated $576K sold.

Deerfield Management first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $7.98M in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Deerfield Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Deerfield Management sold 1,644,583 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $576K.
Deerfield Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
Deerfield Management's Aralez Pharmaceuticals Inc. position peaked at $7.98M in Q3 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Deerfield Management's 13F filing for Q3 2018, filed 14 Nov 2018.